Tellvest

Companies Economy Pulse Mentions Returns Firms & Analysts Pricing About

Loading…

Descriptive analysis built from SEC filings and public earnings transcripts. Not investment advice.

Yujin Park (Robert W. Baird) — Tellvest

Analysts/Yujin Park

Yujin Park

Robert W. Baird

Healthcare

Limited coverage. Only 4 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.

Companies

Questions

Challenge RatePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions.

Challenge Trend

Q3 '25Q2 '26

Focus Areas6 topics

Margin2Demand2Pricing1Geographic Expansion1Capex Investment1Revenue Growth1

Trends4 quarters

Questions per Quarter

Questions

Challenging

Companies Covered

Question History4 questions

CRLCharles River Laboratories1 quarter

2026 Q1

for RMS, 1Q saw increased demand in small models from CRO clients. Was that comment specifically on China

DemandGeographic ExpansionView in transcript →

DGXQuest Diagnostics1 quarter

2025 Q4

Can you quantify the impacts on setting up Fresenius and Corewell? And maybe break out the Project Nova cost in Q4?

Capex InvestmentMarginView in transcript →

LHLabCorp2 quarters

2026 Q2

So outside of the strategic actions benefiting margin, can you talk more about the underlying margin improvement?

MarginPricingView in transcript →

2025 Q3

can you provide more color on bookings between Central Lab and Early Development?

DemandRevenue GrowthView in transcript →